Enzyme inhibiting compounds

Details for Australian Patent Application No. 2010315152 (hide)

Owner Chelsea Therapeutics, Inc.

Inventors Roberts, Michael J.

Agent Fisher Adams Kelly

Pub. Number AU-A-2010315152

PCT Pub. Number WO2011/056957

Priority 61/258,763 06.11.09 US

Filing date 4 November 2010

Wipo publication date 12 May 2011

International Classifications

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/056957 Priority application(s): WO2011/056957

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010315166-Episomal reprogramming with chemicals

2010315151-Microfibrous cellulose and alkaline earth metal ion structured surfactant composition